Literature DB >> 24267295

Pathology of pulmonary hypertension.

Rubin M Tuder1, Elvira Stacher, Jeffrey Robinson, Rahul Kumar, Brian B Graham.   

Abstract

The pathology of pulmonary hypertension includes numerous abnormalities of the intima, media, and adventitia of the pulmonary vascular tree. A recently completed systematic analysis revealed high variability of morphologic measurements within a given pulmonary arterial hypertension (PAH) lung and among all PAH lungs, as well as distinct pathologic subphenotypes, and included a subset of lungs lacking intimal and medial remodeling. There was correlation between perivascular inflammation, remodeling, and hemodynamics. This article summarizes the pathologic features of the normal and abnormal pulmonary circulation, and correlations with animal models.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Endothelial cells; Pulmonary hypertension; Smooth muscle cells; Vascular remodeling

Mesh:

Year:  2013        PMID: 24267295     DOI: 10.1016/j.ccm.2013.08.009

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  53 in total

Review 1.  Discovery of a murine model of clinical PAH: Mission impossible?

Authors:  Zhiyu Dai; You-Yang Zhao
Journal:  Trends Cardiovasc Med       Date:  2016-12-15       Impact factor: 6.677

Review 2.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 3.  SPECT and PET imaging of adrenomedullin receptors: a promising strategy for studying pulmonary vascular diseases.

Authors:  Luis Michel Alonso Martinez; François Harel; Myriam Létourneau; Vincent Finnerty; Alain Fournier; Jocelyn Dupuis; Jean N DaSilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2019-10-15

4.  Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

Authors:  Quyen L Nguyen; Catherine Corey; Pamela White; Annie Watson; Mark T Gladwin; Marc A Simon; Sruti Shiva
Journal:  JCI Insight       Date:  2017-03-09

5.  Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.

Authors:  Karim C El Kasmi; Steven C Pugliese; Suzette R Riddle; Jens M Poth; Aimee L Anderson; Maria G Frid; Min Li; Soni S Pullamsetti; Rajkumar Savai; Maria A Nagel; Mehdi A Fini; Brian B Graham; Rubin M Tuder; Jacob E Friedman; Holger K Eltzschig; Ronald J Sokol; Kurt R Stenmark
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.

Authors:  Jane A Leopold
Journal:  Circulation       Date:  2018-04-24       Impact factor: 29.690

7.  Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.

Authors:  Zhiyu Dai; Maggie M Zhu; Yi Peng; Hua Jin; Narsa Machireddy; Zhijian Qian; Xianming Zhang; You-Yang Zhao
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

Review 8.  Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure: Role of Soluble Epoxide Hydrolase.

Authors:  Mark D Stevenson; Chandrika Canugovi; Aleksandr E Vendrov; Takayuki Hayami; Dawn E Bowles; Karl-Heinz Krause; Nageswara R Madamanchi; Marschall S Runge
Journal:  Antioxid Redox Signal       Date:  2018-12-28       Impact factor: 8.401

Review 10.  Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.

Authors:  Kurt R Stenmark; Maria G Frid; Brian B Graham; Rubin M Tuder
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.